CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Geradts, J.
Right arrow Articles by Minna, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Geradts, J.
Right arrow Articles by Minna, J. D.

Cell Growth & Differentiation, Vol 4, Issue 10 799-809, Copyright © 1993 by American Association of Cancer Research


ARTICLES

Human lung cancer cell lines exhibit resistance to retinoic acid treatment

J Geradts, JY Chen, EK Russell, JR Yankaskas, L Nieves and JD Minna
National Cancer Institute-Navy Medical Oncology Branch, National Naval Medical Center, Bethesda, Maryland 20889.

Retinoic acid (RA) and nuclear retinoic acid receptors (RARs) have been implicated in a variety of human malignancies including lung cancer, and RA has been proposed as a chemopreventive agent for bronchogenic carcinoma. Normal human tracheobronchial epithelial cells show dramatic induction of RAR-beta mRNA and significant growth inhibition after RA treatment. In contrast, 17 of 22 small cell lung cancer (SCLC) and 9 of 15 non-SCLC lines treated with 1 microM RA showed no significant growth inhibition. Of interest, 5 SCLC lines with high levels of myc gene family expression related to c-, N-, or L-myc gene amplification exhibited growth inhibition (28-87%), whereas 2 non-SCLC lines actually showed growth stimulation after treatment with 1 microM RA. The lines varied greatly in their constitutive expression of RAR-beta mRNA, and 15 of 20 SCLC and 8 of 15 non-SCLC lines failed to show RAR-beta mRNA induction after RA treatment. Six cell lines showed possible alterations in the coding region of RAR-beta by complementary DNA (cDNA)/polymerase chain reaction (PCR) analysis using primers common to the RAR-beta1,2,3 isoforms, since other regions would undergo cDNA/PCR amplification whereas the DNA binding domain would not. Nonetheless, no abnormal band shift patterns in cDNA amplified by PCR were found by single strand conformation polymorphism analysis covering all 1344 base pairs of the RAR-beta open reading frame. Finally, no abnormalities in RAR-alpha gene structure or expression were identified by Southern and Northern blot analysis, including lines with cytogenetic abnormalities of 17q21. We conclude that abnormalities of the RAR-beta system are common in human lung cancer cell lines.


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
C. Shao, J. P. Sullivan, L. Girard, A. Augustyn, P. Yenerall, J. Rodriguez-Canales, H. Liu, C. Behrens, J. W. Shay, I. I. Wistuba, et al.
Essential Role of Aldehyde Dehydrogenase 1A3 for the Maintenance of Non-Small Cell Lung Cancer Stem Cells Is Associated with the STAT3 Pathway
Clin. Cancer Res., August 1, 2014; 20(15): 4154 - 4166.
[Abstract] [Full Text] [PDF]


Home page
EMBO Mol Med.Home page
O. A. Romero, F. Setien, S. John, P. Gimenez-Xavier, G. Gomez-Lopez, D. Pisano, E. Condom, A. Villanueva, G. L. Hager, and M. Sanchez-Cespedes
The tumour suppressor and chromatin-remodelling factor BRG1 antagonizes Myc activity and promotes cell differentiation in human cancer
EMBO Mol Med., July 3, 2012; 4(7): 603 - 616.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
O. Arrieta, C. H. Gonzalez-De la Rosa, E. Arechaga-Ocampo, G. Villanueva-Rodriguez, T. L. Ceron-Lizarraga, L. Martinez-Barrera, M. E. Vazquez-Manriquez, M. A. Rios-Trejo, M. A. Alvarez-Avitia, N. Hernandez-Pedro, et al.
Randomized Phase II Trial of All-Trans-Retinoic Acid With Chemotherapy Based on Paclitaxel and Cisplatin As First-Line Treatment in Patients With Advanced Non-Small-Cell Lung Cancer
J. Clin. Oncol., July 20, 2010; 28(21): 3463 - 3471.
[Abstract] [Full Text] [PDF]


Home page
Cancer Prev ResHome page
S. Song, B. Guan, T. Men, A. Hoque, R. Lotan, and X.-C. Xu
Antitumor Effect of Retinoic Acid Receptor-{beta}2 Associated with Suppression of Cyclooxygenase-2
Cancer Prevention Research, March 1, 2009; 2(3): 274 - 280.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Z. D. Liang, S. M. Lippman, T.-T. Wu, R. Lotan, and X.-C. Xu
RRIG1 Mediates Effects of Retinoic Acid Receptor {beta}2 on Tumor Cell Growth and Gene Expression through Binding to and Inhibition of RhoA.
Cancer Res., July 15, 2006; 66(14): 7111 - 7118.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
H. Srinivas, D. M. Juroske, S. Kalyankrishna, D. D. Cody, R. E. Price, X.-C. Xu, R. Narayanan, N. L. Weigel, and J. M. Kurie
c-Jun N-Terminal Kinase Contributes to Aberrant Retinoid Signaling in Lung Cancer Cells by Phosphorylating and Inducing Proteasomal Degradation of Retinoic Acid Receptor {alpha}
Mol. Cell. Biol., February 1, 2005; 25(3): 1054 - 1069.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. S. Kim, H. Lee, H. Kim, Y. M. Shim, J. Han, J. Park, and D.-H. Kim
Promoter Methylation of Retinoic Acid Receptor Beta 2 and the Development of Second Primary Lung Cancers in Non-Small-Cell Lung Cancer
J. Clin. Oncol., September 1, 2004; 22(17): 3443 - 3450.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
E. M. Youssef, D. Lotan, J.-P. Issa, K. Wakasa, Y.-H. Fan, L. Mao, K. Hassan, L. Feng, J. J. Lee, S. M. Lippman, et al.
Hypermethylation of the Retinoic Acid Receptor-{beta}2 Gene in Head and Neck Carcinogenesis
Clin. Cancer Res., March 1, 2004; 10(5): 1733 - 1742.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
S. Zochbauer-Muller, J. D. Minna, and A. F. Gazdar
Aberrant DNA Methylation in Lung Cancer: Biological and Clinical Implications
Oncologist, October 1, 2002; 7(5): 451 - 457.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y.-A. Suh, H.-Y. Lee, A. Virmani, J. Wong, K. K. Mann, W. H. Miller Jr., A. Gazdar, and J. M. Kurie
Loss of Retinoic Acid Receptor {beta} Gene Expression Is Linked to Aberrant Histone H3 Acetylation in Lung Cancer Cell Lines
Cancer Res., July 15, 2002; 62(14): 3945 - 3949.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X. Guo, D. M Nanus, A. Ruiz, R. R Rando, D. Bok, and L. J Gudas
Reduced Levels of Retinyl Esters and Vitamin A in Human Renal Cancers
Cancer Res., March 1, 2001; 61(6): 2774 - 2781.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
S. Zochbauer-Muller, K. M. Fong, A. K. Virmani, J. Geradts, A. F. Gazdar, and J. D. Minna
Aberrant Promoter Methylation of Multiple Genes in Non-Small Cell Lung Cancers
Cancer Res., January 1, 2001; 61(1): 249 - 255.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Wan, W. K. Hong, and R. Lotan
Increased Retinoic Acid Responsiveness in Lung Carcinoma Cells that Are Nonresponsive Despite the Presence of Endogenous Retinoic Acid Receptor (RAR) {beta} by Expression of Exogenous Retinoid Receptors Retinoid X Receptor {{alpha}}, RAR{{alpha}}, and RAR{{gamma}}
Cancer Res., January 1, 2001; 61(2): 556 - 564.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
S. Y. Kim, H. Adachi, J. S. Koo, and A. M. Jetten
Induction of the Cytochrome P450 Gene CYP26 during Mucous Cell Differentiation of Normal Human Tracheobronchial Epithelial Cells
Mol. Pharmacol., September 1, 2000; 58(3): 483 - 490.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
F. R. Khuri, R. Lotan, B. L. Kemp, S. M. Lippman, H. Wu, L. Feng, J. J. Lee, C. S. Cooksley, B. Parr, E. Chang, et al.
Retinoic Acid Receptor-Beta as a Prognostic Indicator in Stage I Non-Small-Cell Lung Cancer
J. Clin. Oncol., August 15, 2000; 18(15): 2798 - 2804.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. M. Kurie, J. S. Lee, F. R. Khuri, L. Mao, R. C. Morice, J. J. Lee, G. L. Walsh, A. Broxson, S. M. Lippman, J. Y. Ro, et al.
N-(4-Hydroxyphenyl)Retinamide in the Chemoprevention of Squamous Metaplasia and Dysplasia of the Bronchial Epithelium
Clin. Cancer Res., August 1, 2000; 6(8): 2973 - 2979.
[Abstract] [Full Text]


Home page
J Biol ChemHome page
S.-Y. Sun, H. Wan, P. Yue, W. K. Hong, and R. Lotan
Evidence That Retinoic Acid Receptor {beta} Induction by Retinoids Is Important for Tumor Cell Growth Inhibition
J. Biol. Chem., June 2, 2000; 275(22): 17149 - 17153.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Sueoka, H.-Y. Lee, G. L. Walsh, W. K. Hong, and J. M. Kurie
Posttranslational Mechanisms Contribute to the Suppression of Specific Cyclin: CDK Complexes by All-Trans Retinoic Acid in Human Bronchial Epithelial Cells
Cancer Res., August 1, 1999; 59(15): 3838 - 3844.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
W. J. Berg, D. M. Nanus, A. Leung, K. T. Brown, B. Hutchinson, M. Mazumdar, X.-C. Xu, R. Lotan, V. E. Reuter, and R. J. Motzer
Up-Regulation of Retinoic Acid Receptor {beta} Expression in Renal Cancers in Vivo Correlates with Response to 13-cis-Retinoic Acid and Interferon-{{alpha}}-2a
Clin. Cancer Res., July 1, 1999; 5(7): 1671 - 1675.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X.-C. Xu, X. Liu, E. Tahara, S. M. Lippman, and R. Lotan
Expression and Up-Regulation of Retinoic Acid Receptor-{beta} Is Associated with Retinoid Sensitivity and Colony Formation in Esophageal Cancer Cell Lines
Cancer Res., May 1, 1999; 59(10): 2477 - 2483.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Sakaue, H. Adachi, and A. M. Jetten
Post-Transcriptional Regulation of MyD118 and GADD45 in Human Lung Carcinoma Cells During 6-[3-(1-Adamantyl)-4-hydroxyphenyl]-2-naphthalene Carboxylic Acid-Induced Apoptosis
Mol. Pharmacol., April 1, 1999; 55(4): 668 - 676.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S.-Y. Sun, J. M. Kurie, P. Yue, M. I. Dawson, B. Shroot, R. A. S. Chandraratna, W. K. Hong, and R. Lotan
Differential Responses of Normal, Premalignant, and Malignant Human Bronchial Epithelial Cells to Receptor-selective Retinoids
Clin. Cancer Res., February 1, 1999; 5(2): 431 - 437.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
B.-j. M. van der Leede, C. E. van den Brink, W. W. M. Pijnappel, E. Sonneveld, P. T. van der Saag, and B. van der Burg
Autoinduction of Retinoic Acid Metabolism to Polar Derivatives with Decreased Biological Activity in Retinoic Acid-sensitive, but Not in Retinoic Acid-resistant Human Breast Cancer Cells
J. Biol. Chem., July 18, 1997; 272(29): 17921 - 17928.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
S.-Y. Sun, H. Wan, P. Yue, W. K. Hong, and R. Lotan
Evidence That Retinoic Acid Receptor {beta} Induction by Retinoids Is Important for Tumor Cell Growth Inhibition
J. Biol. Chem., June 2, 2000; 275(22): 17149 - 17153.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1993 by the American Association of Cancer Research.